The study of aqueous extract of Pterocarpus marsupium Roxb. on cytokine TNF- in type 2 diabetic rats

Indian Journal of Pharmacology

Volumn 42, Issue 6, 2010, Pages 392-396

  Halagappa, Kirana ^a   Girish, H N ^b   Srinivasan, B P ^a  

^a DELHI INSTITUTE OF PHARMACEUTICAL SCIENCES AND RESEARCH   (India)

^b TVM College of Pharmacy   (India)

Author keywords

Cytokine; Pterocarpus marsupium; TNF ; Type 2 diabetes

Indexed keywords

ANTIDIABETIC AGENT; GLUCOSE; KINO EXTRACT; PLANT EXTRACT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CHRONIC INFLAMMATION; CONTROLLED STUDY; DRUG ACTIVITY; FEMALE; GLUCOSE BLOOD LEVEL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PROTEIN BLOOD LEVEL; PTEROCARPUS; PTEROCARPUS MARSUPIUM; RAT; STREPTOZOCIN DIABETES;

EID: 78149369089     PISSN: 02537613     EISSN: 19983751     Source Type: Journal    
DOI: 10.4103/0253-7613.71922     Document Type: Article

References (32)

1. Manning PJ, De Jong SA, Sultherland WH, McGrath M, Williams SM. Changes in circulating postprandial proinflammatory cytokine concentration in diet-controlled type 2 diabetes and the effect of ingested fat. Diabetes Care 2004;27:2509-11.
2. Spranger J, Kroke A, Mohlig M, Hoffmann K, Manuela M, Bergmann M, et al. Inflammatory cytokines and the risk to develop Type 2 Diabetes. Diabetes 2003;52:812-7.
3. Pickup JC. Inflammation and activated immunity in the pathogenesis of Type 2 Diabetes. Diabetes care 2004;27:813-23.
4. Van de Kar LD, Carrasco GA. Neuroendocrine pharmacology of stress. Eur J Pharmacol 2003;463:235-72.
5. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and Insulin resistance. J Clin Invest 1995;95:2409-15.
6. Hu FB, Meigs JB, Li TY, Rifai N, Manson JE. Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes 2004;53:693-700. (Pubitemid 38270639)
7. Koga M, Otsuki M, Kubo M, Hashimoto J, Kasayama S. Relationship between circulating vascular cell adhesion molecule-1 and microvascular complications in type 2 diabetes mellitus. Diabet Med 1998;15:661-7.
8. Agnivesha. Prameha Chikitsa. Charaka Samhita. 5th ed. Varanasi: Choukamba Sanskrita Samsthana; 2001. p. 446-7.
9. Govindarajan R, Pushpangadan P, Vijayakumar M. Anti-oxidant approach to disease management and role of rasayana herbs of Ayurveda. J Ethnopharmacol 2005;99:165-78.
10. Rajasekharan S, Tuli SN. Vijayasara, Pterocarpus marsupium in the treatment of madhumeha (diabetes mellitus)-A Clinical trial. J Res Indian Med Yoga Homeo 1976;11:9-14.
11. Dhanabal SP, Suresh B, Kokate CK, Ramanathan M, Kumar EP. Hypoglycemic activity of Pterocarpus marsupium Roxb. Phytother Res 2006;20:4-8.
12. Manickam M, Ramanathan M, Jahromi MA, Chansouria JP, Ray AB. Antihyperglycemic activity of phenolics from Pterocarpus marsupium. J Nat Prod 1997;60:609-10.
13. Kidwai JR, Ahamad F, Khalid P, Khan MM, Chaubey M, Rastogi AK. Hypoglycemic activity of Pterocarpus marsupium wood. J Ethnopharmacol 1991;35:71-5.
14. Maurya R, Singh R, Deepak M, Handa SS, Yadav PP, Mishra PK. Constituents of Pterocarpus marsupium: An ayurvedic crude drug. Phytochemistry 2004;65:915-20.
15. Goel RK, Joshi MC, Dorababu M, Prabha T, Kumar MM. Effect of Pterocarpus marsupium on NIDDM-induced rat gastric ulceration and mucosal offensive and defensive factors. Indian J Pharmacol 2004;36:296-302.
16. Kar A, Choudhary BK, Bandyopadhyay NG. Comparative evaluation of hypoglycemic activity of some Indian medicinal plants in alloxan diabetic rats. J Ethnopharmacol 2003;84:105-8.
17. Bonner-Weir S, Trent DF, Honey RN, Weir GC. Responses of neonatal rat islets to streptozotocin. Diabetes 1981;30:64-9.
18. Flexible dose open trial of vijayasar in cases of newly-diagnosed non-insulin dependent diabetes mellitus. Indian Council of Medical Research (ICMR) collaborating centers, Central biostatistical monitoring unit, Chennai and central technical co-ordinating unit, ICMR, New Delhi. Indian J Med Res 1998;108:24-9.
19. Trinder P. Determination of blood glucose using an oxidase-peroxidase system with a non carcinogenic chromogen. J Clin Pathol 1969;22:158-61.
20. Baron AD. Postprandial hyperglycemia and α-glucosidase inhibitors. Diabetes Res Clin Pract 1998;40:S51-5.
21. Rao YK, Fang SH, Tzeng YM. Anti-inflammatory activities of flavonoids isolated from Caesalpinia pulcherrima. J Ethnopharmacol 2005;100:249-53.
22. Ahmed N. Advanced glycation end products- role in pathology of diabetic complication. Diabetes Res Clin Pract 2005;67:3-21.
23. Ratner RE. Controlling postprandial hyperglycemia. Am J Cardiol 2001;88:26H-31.
24. Chakravarthy BK, Gupta S, Gambhir SS, Gode KD. Pancreatic β-cell regeneration-A novel anti diabetic mechanism of Pterocarpus marsupium Roxb. Indian J Pharmacol 1980;12:123-7.
25. Hii CS, Howell SL. Effect of epicatechin on rat islets of langerhans. Diabetes 1984;33:291-6.
26. Virkamaki A, Ueki K, Kahn CR. Protein-Protein interaction in insulin signaling and the molecular mechanism of insulin resistance. J Clin Invest 1999;103:931-43.
27. Tataranni PA, Ortega E. Does an adipokine induced activation of the immune system mediate the effect of over nutrition on Type 2 Diabetes? Diabetes 2005;54:917-27.
28. Brahma SK, Debnath PK. Therapeutic importance of rasayana drugs with a special reference to their multi-dimensional actions. Aryavaidyan 2003;16:160-3.
29. Devasagayam TP, Sainis KB. Immune system and antioxidants, especially those derived from Indian medicinal plants. Indian J Exp Biol 2002;40:639-55.
30. Saraf S, Singh MA, Saraf A. Flavonoids: A nutritional protection against oxidative and UV induced cellular damages. Pharmacog Rev 2007;1:30-40.
31. Berger JP, Akiyama TE, Meinke PT. PPARs: Therapeutic targets for metabolic disease. Trends Pharmacol Sci 2005;26:244-51.
32. Vishwakarma RA, Balakrishnan A, Anandharajan R, Pathmanathan K, Shankernarayana NP. Upregulation of Glut-4 and PPARγ by an isoflavone from Pterocarpus marsupium on L6 myotubes: A possible mechanism of action. J Ethnopharmacol 2005;97:253-60.